AI Article Synopsis

  • HPV self-sampling kits can significantly improve cervical cancer screening rates among women who are usually under-screened compared to traditional methods where a healthcare professional takes samples.
  • A systematic review of 33 randomised controlled trials showed that all self-sampling invitation methods were more effective at increasing participation than standard invitations, with the highest participation from community outreach efforts.
  • Opt-in invitation strategies were found to be less effective than universal mailings, suggesting that sending kits to all eligible women may lead to better screening outcomes.

Article Abstract

Background: Human papillomavirus (HPV) testing on self-samples represents a great opportunity to increase cervical cancer screening uptake among under-screened women.

Methods: A systematic review and meta-analysis on randomised controlled trials (RCTs) were performed to update the evidence on the efficacy of strategies for offering self-sampling kits for HPV testing compared to conventional invitations and to compare different self-sampling invitation scenarios. Four experimental invitational scenarios were considered. Women in the control group were invited for screening according to existing practice: collection of a cervical specimen by a healthcare professional. Random-effects models were used to pool proportions, relative participation rates and absolute participation differences.

Results: Thirty-three trials were included. In the intention-to-treat analysis, all self-sampling invitation scenarios were more effective in reaching under-screened women compared to controls. Pooled participation difference (PD) and 95% confidence interval (CI) for experimental vs. control was 13.2% (95% CI = 11.0-15.3%) for mail-to-all, 4.4% (95% CI = 1.2-7.6%) for opt-in, 39.1% (95% CI = 8.4-69.9%) for community mobilisation & outreach and 28.1% (23.5-32.7%) for offer at healthcare service. PD for the comparison opt-in vs. mail-to-all, assessed in nine trials, was -8.2% (95% CI = -10.8 to -5.7%).

Discussion: Overall, screening participation was higher among women invited for self-sampling compared to control, regardless of the invitation strategy used. Opt-in strategies were less effective than send-to-all strategies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977737PMC
http://dx.doi.org/10.1038/s41416-022-02094-wDOI Listing

Publication Analysis

Top Keywords

self-sampling kits
8
cervical cancer
8
cancer screening
8
hpv testing
8
self-sampling invitation
8
invitation scenarios
8
self-sampling
5
participation
5
95%
5
offering hpv
4

Similar Publications

: Implementing self-sampling (SS) in cervical cancer screening requires comparable results to clinician-collected samples (CCS). Agreement measures are essential for evaluating HPV test performance. Previous studies on non-paired samples have reported higher viral cycle threshold (Ct) values in SS compared to CCS, affecting sensitivity for detecting cervical intraepithelial neoplasia grade 2 or worse (CIN2+).

View Article and Find Full Text PDF

Background And Objectives: We are reporting the performance of HPV self-sample collected by a novel kit in comparison with clinician collected cervical sample for HPV testing for cervical cancer screening.

Methods: Consenting, eligible women aged 25 to 60, with a positive cervical cancer screening test report in the past one year but without any prior treatment for cervical abnormalities were enrolled in the study. Each woman provided 2 samples for the HPV test (vaginal self-sample collected with the CERVICHECKTM, an indigenous kit from India and cervical sample collected by the clinician).

View Article and Find Full Text PDF
Article Synopsis
  • The widespread use of smartphones has led to the development of innovative telemedicine solutions, especially for SARS-CoV-2 PCR testing during the COVID-19 pandemic, which requires contactless healthcare.
  • This feasibility study compared traditional healthcare professional-performed testing with a telemedicine-guided self-sampling approach, focusing on practicality, user satisfaction, and economic implications.
  • Results showed high user satisfaction in the telemedicine group, with 76% returning samples, higher test completion rates than the conventional group, but at a slightly increased cost; the study indicates the potential for effective data sharing through a mobile app.
View Article and Find Full Text PDF

Simple and easy to use kits for SARS-Cov-2 self-testing during epidemic waves are needed to optimize diagnostic capacity in low- and middle-income countries. SARS-Cov-2 self-testing kits are available, but application of these novel diagnostic technologies is less understood in low and middle-income contexts. We investigated the ability to understand and perform instructions for use (IFUs) for STANDARD Q COVID-19 Ag Test (SD Biosensor) and Panbio COVID-19 Ag Rapid Test Device (Abbott Rapid Diagnostics) for anterior nares (AN) nasal self-sampling and self-testing for COVID-19 in rural and urban Malawi.

View Article and Find Full Text PDF

Broad accessibility to cervical cancer screening and high participation rate is essential to reduce cervical cancer incidence. HPV self-sampling is an alternative to clinician collected cervical samples to increase accessibility and screening coverage. To inform on deployment strategies of HPV self-sampling, this large-scale, randomized, pragmatic study compared two invitation modalities; direct-mail and opt-in.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!